<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Clinical &amp; Molecular Biomedicine</journal-title>
      </journal-title-group>
      <issn>Pending</issn>
      <publisher>
        <publisher-name>EditoryPress</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">cmb-v1i1-002</article-id>
      <article-id pub-id-type="doi">10.53295/cmi.opPvITpPds</article-id>
      <title-group>
        <article-title>Molecular Insights into Arylsulfatase B Mutation-Induced Instability in Mucopolysaccharidosis Type VI</article-title>
      </title-group>
      <contrib-group><contrib contrib-type="author"><name><given-names>Barka</given-names><surname>Basharat</surname></name><aff><institution>Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi, India</institution></aff></contrib><contrib contrib-type="author"><name><given-names>Nushrat</given-names><surname>Jahan</surname></name><aff><institution>Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi, India</institution></aff></contrib><contrib contrib-type="author"><name><given-names>Mohammad Asim</given-names><surname>Azhar</surname></name><aff><institution>Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research, Riyadh, Kingdom of Saudi Arabia</institution></aff><email>azharasim@gmail.com</email></contrib></contrib-group>
      <pub-date publication-format="electronic">
        <day>05</day>
        <month>01</month>
        <year>2026</year>
      </pub-date>
      <volume>1</volume>
      <issue>1</issue>
      <self-uri xlink:href="https://editorypress.uz/find-a-journal/clinical-molecular-biomedicine/about-article/cmb-v1i1-002"/>
      <self-uri content-type="pdf" xlink:href="https://editorypress.uz/landing/find-a-journal/6/pdfs/barka_molecular_insight.pdf"/>
      <permissions>
        <license><license-p>CC BY 4.0 Open Access</license-p></license>
        <copyright-statement>Open Access</copyright-statement>
      </permissions>
      <abstract><p>Mutations in the arylsulfatase B (ARSB) gene are directly implicated in mucopolysaccharidosis type VI (MPS VI). Several non-synonymous single-nucleotide polymorphisms (nsSNPs) in ARSB have been associated with disease pathogenesis. A comprehensive evaluation of these variants is essential to understand their structural and functional consequences. In this study, a systematic in silico analysis was performed to identify deleterious nsSNPs in the ARSB gene. Initially, 430 nsSNPs were evaluated using sequence-based prediction tools, including SIFT, PolyPhen-2, FATHMM, and Mutation Assessor. Subsequently, 141 nsSNPs were subjected to structure-based stability analysis using MAESTROweb, SDM2, mCSM, and DynaMut2, of which 57 variants overlapped with previous reports. High-confidence deleterious nsSNPs were further assessed for pathogenicity using PMut and MutPred2 servers. Our integrated computational approach identified 44 highly deleterious mutations. Aggregation propensity analysis revealed that 29 of these variants exhibit increased aggregation tendencies, while one variant demonstrated progressive loss of solubility. Molecular dynamics simulations further indicated that high-confidence deleterious nsSNPs significantly disrupt ARSB structural integrity, enhance molecular flexibility, reduce structural rigidity, and promote atomic-level aggregation. Overall, this study provides mechanistic insights into how pathogenic mutations destabilize the ARSB protein and contribute to MPS VI pathogenesis, highlighting potential targets for future therapeutic investigation.</p></abstract>
      <kwd-group><kwd>ARSB gene</kwd><kwd>mucopolysaccharidosis type VI</kwd><kwd>non-synonymous SNPs</kwd><kwd>pathogenic mutations</kwd><kwd>protein stability</kwd><kwd>protein aggregation</kwd><kwd>genetic variation</kwd><kwd>computational mutagenesis</kwd></kwd-group>
    </article-meta>
  </front>
</article>
